We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Device Makes Heart Ablations Safer by Gently Diverting Esophagus

By HospiMedica International staff writers
Posted on 22 May 2023

Atrial fibrillation (AFib), the most prevalent heart rhythm issue, impacts millions of people and significantly escalates their risk of stroke and heart failure. More...

For certain AFib patients, a catheter ablation, which involves burning or freezing the precise problematic area, is employed to restore a regular heart rhythm. This can be effective in treating AFib, although the energy from the catheter tip can cause severe damage to the nearby esophagus, situated just a few millimeters away. Now, a new device gently shifts the esophagus away from the danger zone during a catheter ablation to prevent potential life-threatening injuries, thereby enhancing patient safety significantly.

While performing a catheter ablation procedure, surgeons strive to deliver high energy and devote considerable time to ablating a specific spot in order to achieve a good, deep lesion. At the same time, they are highly aware of the esophagus's location and must take great care to prevent any harm from coming to that structure. With the new device developed by an electrophysiologist at The Ohio State University (Columbus, OH, USA), surgeons can employ suction force to draw in the esophagus and subsequently shift the entire segment about an inch aside to successfully establish a safe path for delivering energy during the catheter ablation procedure.

A clinical trial spearheaded by Ohio State revealed that over a third of heart ablation patients suffered esophageal injuries without the device. In contrast, when the innovative device was employed, less than 5% of patients incurred any esophageal damage, and those injuries were notably less severe than in the control group.

“There have been attempts to protect the esophagus during heart ablations in the past using different techniques like measuring the temperature inside the esophagus, using ultrasound imaging to identify where it’s located and using shorter or less intense ablation energy, but esophageal injury continued to be a serious problem,” said Emile Daoud, MD, electrophysiologist and clinical professor of internal medicine at the medical center. “With this device, patients can rest assured that they are getting the safest procedure possible without compromising any benefits to their heart.”

Related Links:
The Ohio State University 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.